Q/C Technologies, Inc. Payments to Acquire Productive Assets
Q/C Technologies, Inc. (QCLS) reported Payments to Acquire Productive Assets of $1.75 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-12
- Q/C Technologies, Inc. payments to acquire productive assets for the quarter ending 2018-09-30 was $16.30K.
- Q/C Technologies, Inc. payments to acquire productive assets for the quarter ending 2018-06-30 was $522.00, a 1640.00% increase year-over-year.
- Q/C Technologies, Inc. payments to acquire productive assets for the quarter ending 2018-03-31 was $23.80K, a 42.17% increase year-over-year.
- Q/C Technologies, Inc. payments to acquire productive assets for the quarter ending 2017-12-31 was $24.96K, a 87.82% decline year-over-year.
- Q/C Technologies, Inc. payments to acquire productive assets for fiscal 2025 was $1.75M.
- Q/C Technologies, Inc. payments to acquire productive assets for fiscal 2017 was $41.73K, a 79.85% decline from fiscal 2016.
- Q/C Technologies, Inc. payments to acquire productive assets for fiscal 2016 was $207.13K.
| Period end | Payments to Acquire Productive Assets | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 3 month as first filed | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.75M 10-K · filed 2026-04-15 | |||||
| 2025-09-02 | $1.75M 10-Q · filed 2026-08-12 | |||||
| 2018-09-30 | $16.30K 10-Q · filed 2018-11-14 | $16.82K derived: sum of 2 quarters · filed 2018-11-14 | $20.94K 10-Q · filed 2018-11-14 | $65.58K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2018-06-30 | $522.00 10-Q · filed 2018-08-14 | $4.64K 10-Q · filed 2018-08-14 | $49.28K derived: sum of 3 quarters · filed 2018-08-14 | $49.28K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2018-03-31 | $23.80K 10-Q · filed 2018-07-13 | $48.76K derived: sum of 2 quarters · filed 2018-07-13 | $48.76K derived: sum of 3 quarters · filed 2018-11-14 | $48.79K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-12-31 | $24.96K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-07-13 | $24.96K derived: sum of 2 quarters · filed 2018-11-14 | $24.99K derived: sum of 3 quarters · filed 2018-11-14 | $41.73K 10-K/A · filed 2018-07-13 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $30.00 derived: sum of 2 quarters · filed 2018-11-14 | $16.77K 10-Q · filed 2018-11-14 | $221.62K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $30.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $16.77K 10-Q · filed 2018-08-14 | $221.62K derived: sum of 3 quarters · filed 2018-08-14 | $193.87K derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $16.74K 10-Q · filed 2018-07-13 | $16.77K 10-Q · filed 2017-05-15 | $221.59K derived: sum of 2 quarters · filed 2018-07-13 | $193.84K derived: sum of 3 quarters · filed 2018-07-13 | $223.88K derived: sum of 4 quarters · filed 2018-07-13 | |
| 2016-12-31 | $204.85K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13 | $177.09K derived: sum of 2 quarters · filed 2018-07-13 | $207.13K derived: sum of 3 quarters · filed 2018-07-13 | $207.13K 10-K/A · filed 2018-07-13 | ||
| 2016-09-30 | -$27.76K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-07-13 | $2.29K derived: sum of 2 quarters · filed 2018-07-13 | $2.29K 10-Q/A · filed 2018-07-13 | |||
| 2016-06-30 | $30.04K 10-Q/A · filed 2018-07-13 | $30.04K 10-Q/A · filed 2018-07-13 | ||||
| 2016-03-31 | $3.08K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |